Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
56,964,566
-
Share change
-
-3,714,556
-
Total reported value
-
$119,040,607
-
Put/Call ratio
-
74%
-
Price per share
-
$2.09
-
Number of holders
-
155
-
Value change
-
-$1,729,520
-
Number of buys
-
102
-
Number of sells
-
63
Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q2 2025
As of 30 Jun 2025 Humacyte, Inc. - COM (HUMA) had 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 56,964,566 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, CenterBook Partners LP, GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP, MILLENNIUM MANAGEMENT LLC, UBS Group AG, Woodline Partners LP, and TWO SIGMA INVESTMENTS, LP.
This table shows 155 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.